Clinical trial
Impact of Kremezin on Renal Recovery and Uremic Toxin Levels in Patients With Acute Kidney Disease
NCT07182422 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Kremezin on Renal Recovery and Uremic Toxin Levels in Patients With Acute Kidney Disease
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 15, 2025
- Completion date
- March 13, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney disease, acute kidney injury (aki)